121 related articles for article (PubMed ID: 7107795)
1. Determination of apovincaminic acid in human plasma by gas-liquid chromatography.
Polgár M; Vereczkey L
J Chromatogr; 1982 May; 241(1):29-32. PubMed ID: 7107795
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous evaluation of apovincaminic acid esters and their metabolite apovincaminic acid by solvent partition and GLC in biological samples. Preliminary data with MR 711.
Marzo A; Quadro G; Stradi R; Saccarello ML; Molteni L; Bruno G
Arzneimittelforschung; 1981; 31(10):1681-4. PubMed ID: 7198444
[TBL] [Abstract][Full Text] [Related]
3. Determination of apovincaminic acid in biological samples by high-performance liquid chromatography.
Kozma M; Pudleiner P; Vereczkey L
J Chromatogr; 1982 May; 241(1):177-82. PubMed ID: 7107794
[TBL] [Abstract][Full Text] [Related]
4. Determination of apovincaminic acid in serum by means of high-performance liquid chromatography.
Kraus G; Schulz HU; Lohmann A
J Chromatogr; 1992 Jan; 573(2):323-7. PubMed ID: 1601968
[TBL] [Abstract][Full Text] [Related]
5. Determination of vinpocetine and its primary metabolite, apovincaminic acid, in rat plasma by liquid chromatography-tandem mass spectrometry.
Xia HM; Su LN; Guo JW; Liu GM; Pang ZQ; Jiang XG; Chen J
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):1959-66. PubMed ID: 20561830
[TBL] [Abstract][Full Text] [Related]
6. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography.
Maya MT; Pais JP; Araújo HM; Morais JA
J Pharm Biomed Anal; 1996 Mar; 14(5):617-22. PubMed ID: 8738192
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
Miskolczi P; Kozma K; Polgár M; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
[TBL] [Abstract][Full Text] [Related]
9. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580
[TBL] [Abstract][Full Text] [Related]
10. Improved gas chromatographic-mass spectrometric method for the quantitative determination of vinpocetine in human plasma.
Vatsova M; Tzvetanov S; Drenska A; Goranscheva J; Tyutyulkova N
J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):221-6. PubMed ID: 9449575
[TBL] [Abstract][Full Text] [Related]
11. Development of a sensitive enzyme immunoassay for the determination of vinpocetine in human plasma.
Reck B; Dingler E; Lohmann A
Arzneimittelforschung; 1992 Oct; 42(10):1171-4. PubMed ID: 1472136
[TBL] [Abstract][Full Text] [Related]
12. New HPLC-MS method for quantitative determination of apovincaminic acid in human plasma.
Vlase L; Imre S; Leucuta S
J Sep Sci; 2006 Feb; 29(3):385-9. PubMed ID: 16544880
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of vinpocetine (Cavinton) in dog.
Polgár M; Vereczkey L
Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
Miskolczi P; Vereczkey L; Szalay L; Göndöc C
Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of vinpocetine in human plasma by capillary gas chromatography-mass spectrometry.
Hammes W; Weyhenmeyer R
J Chromatogr; 1987 Jan; 413():264-9. PubMed ID: 3558678
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
Vlase L; Bodiu B; Leucuta SE
Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Determination of Vinpocetine and its Major Active Metabolite Apovincaminic Acid in Rats by UPLC-MS/MS and its Application to the Brain Tissue Distribution Study.
Wang M; Wang L; Sun J; Zhang L; Zhao L; Xiong Z
J Chromatogr Sci; 2018 Mar; 56(3):225-232. PubMed ID: 29206914
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of apovincaminic acid in dogs.
Vereczkey L; Pudleiner P
Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
[TBL] [Abstract][Full Text] [Related]
19. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Tamaki N; Kusunoki T; Matsumoto S
Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
[No Abstract] [Full Text] [Related]
20. Study on the absorption of vinpocetine and apovincaminic acid.
Pudleiner P; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
